·¬ΗΡΙηΗψapp

Meeting Coverage

SUO

Society of Urologic Oncology

TULSA Effective in Controlling Prostate Cancer Long-Term

At 5 years, median PSA was reduced by 90%

SUO over a photo of the Omni Shoreham Hotel in Washington, DC.

Latest SUO Meeting Coverage

'Watch and Wait' With Small Renal Masses: When and How Should Docs Intervene?

Phillip Pierorazio, MD, outlines how to be a good steward of active surveillance

December 4, 2023
First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response

A quarter patients with high-risk, BCG-unresponsive disease were recurrence free at 3 years

December 4, 2023
Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer

Results from interim analysis suggest "potential to disrupt the NMIBC treatment landscape"

December 1, 2023
Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancer

Investigational intravesical solution led to complete response rate of 79%

November 30, 2023
Can Oncologists Reduce the Suicide Risk in Their Prostate Cancer Patients?

Barriers exist in identifying risk, but strategies are available

December 6, 2022
Aging U.S. Population a Challenge for Oncologists

Older patients will have different care goals, preferences, geriatric oncologist says

December 5, 2022
To Combat Opioid Epidemic, Step Up Safe Prescribing Practices, Expert Urges

Overprescribing a continuing problem, Benjamin Davies tells urologists

December 2, 2022
Pre-Op Axitinib Helps for Partial Nephrectomy of Complex Renal Tumors

Approach in small ongoing trial resulted in reduction in tumor size and complexity

December 2, 2022
Sequential Gemcitabine/Docetaxel Promising in NMIBC After BCG Relapse

But patients with BCG-refractory disease may be better suited for cystectomy

December 2, 2022
Gene Therapy Hits Its Goal in BCG-Unresponsive NMIBC

In phase III trial, 53% achieved complete response at 3 months

December 6, 2019
Living Near Oil Refinery Tied to Greater Bladder Cancer Risk

Past data support "biological plausibility" for link, says researcher

December 6, 2019
Beta Blockers No Help in Advanced Prostate Cancer

Findings question earlier retrospective data that pointed to possible survival benefit

December 5, 2019
Docetaxel First May Boost Survival in mCRPC

Superior outcomes observed versus approach where chemo follows newer agents

December 5, 2019